DDL, a provider of package, product, and material testing services, will showcase its drug-delivery testing capabilities at Interphex Booth #1143.   

To meet the growing demand for high-quality GMP testing for devices such as auto injectors, pre-filled syringes, inhalers, and other combination products DDL offers the following testing services:  

• Pre-filled Syringes (ISO 11040) 

• Needle-based Injection Systems (ISO 11608) 

• Syringe/Needle Testing (ISO 7864, ISO 7886, ISO 9626) 

• Elastomer Closure (USP 381 & USP 382) 

• Particulate analysis (USP 788 & USP 381) 

• Container Closure Integrity (USP 1207) 

• Shelf-life/ICH Stability Studies/Photostability Studies 

• ISO 11607 packaging validation 

These test are all performed at DDL’s FDA registered 10,600 square foot GMP lab located near DDL’s Eden Prairie, MN headquarters. 

“As the combination product market continues to grow, our GMP facility helps ensure that our medical device and pharmaceutical clients have access to the expertise and resources they need to bring safe and effective products to market,” said Aaron Liss, Director of Sales & Marketing, DDL, Inc. “DDL is committed to excellence in testing services for the life sciences industry and remains focused on delivering precise, reliable, and regulatory-compliant results to support clients in their product development, regulatory submissions and commercial lot release requirements.” 

For more information on DDL’s testing services, or to receive a quote, please contact DDL at [email protected] or call us at 800-229-4235.